Investor AB reported 7 positions with a total reported value of $14.4B as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: AZN ASTRAZENECA PLC (67.9%), NDAQ NASDAQ INC (32.0%), MDWD MEDIWOUND LTD (<0.1%), CLBT CELLEBRITE DI LTD (<0.1%), MU MICRON TECHNOLOGY INC (<0.1%). Against 2026-03-31 it opened 1 new position and exited 4. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Investor AB files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| AZN ASTRAZENECA PLC | 51,587,810 | $9.8B | 67.9% |
| NDAQ NASDAQ INC | 58,439,208 | $4.6B | 32.0% |
| MDWD MEDIWOUND LTD | 872,093 | $12.8M | <0.1% |
| CLBT CELLEBRITE DI LTD | 75,000 | $1.1M | <0.1% |
| MU MICRON TECHNOLOGY INC | 470 | $542.5K | <0.1% |
| VZ VERIZON COMMUNICATIONS INC | 11,300 | $478.4K | <0.1% |
| BMRN BIOMARIN PHARMACEUTICAL INC | 3,700 | $211.7K | <0.1% |
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| MU MICRON TECHNOLOGY INC | 470 | $542.5K | <0.1% |
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| NDAQ NASDAQ INC | 58,382,426 | 58,439,208 | +0.1% | $4.6B |
| CLBT CELLEBRITE DI LTD | 55,000 | 75,000 | +36.4% | $1.1M |
No position was decreased.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms
No password to create and no card required. We store your email address and nothing else.